Sickle cell care and registry in Zimbabwe (SHAZ)

Sickle Hemoglobinopathy reseArch in Zimbabwe (SHAZ)

NIH-funded research College of Health Scis Univ of Zimbabwe · NIH-11092924

This program will enroll people with sickle cell disease in Zimbabwe and Zambia to collect health information and blood samples to help improve diagnosis and treatment.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionCollege of Health Scis Univ of Zimbabwe NIH-funded
Lab location1 site (Harare, Zimbabwe)
Project IDNIH-11092924 on NIH RePORTER

What this research studies

If you join SHAZ, you would be asked to share health information, have routine clinical checks, and give small blood samples that go into a secure registry and biorepository. The team plans to enroll about 4,000 people across Zimbabwe and Zambia and follow them over several years to learn how sickle cell affects children and adults. Researchers will run three linked cohort studies, including one looking at whether low fetal hemoglobin and abnormal cerebral blood flow raise the risk of stroke. The project also trains local clinicians and works to expand newborn screening, better nutrition, and access to hydroxyurea at participating clinics.

Who could benefit from this research

Good fit: People of any age with sickle cell disease who can attend clinics in Zimbabwe or Zambia, including newborns, children, and adults, are ideal candidates.

Not a fit: People without sickle cell disease, those living far from participating clinics, or those unwilling to provide samples and attend follow-up are unlikely to benefit directly.

Why it matters

Potential benefit: If successful, this work could help prevent strokes, enable earlier diagnosis in newborns, and widen access to treatments like hydroxyurea for people with sickle cell disease.

How similar studies have performed: Registries and hydroxyurea programs elsewhere have improved outcomes, but large coordinated cohort and stroke-risk studies in this part of sub‑Saharan Africa are relatively recent.

Where this research is happening

Harare, Zimbabwe

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.